Association between migraine and risk of stroke: a systematic review and meta-analysis
Abstract
BACKGROUND: Results regarding the association between migraine and risk of stroke are inconsistent.
METHODS: A literature search of the databases (Web of Science, Google Scholar and PubMed) was made before December 2021. STATA 12.0 software was used. Odds ratios (ORs) or relative risks (RRs) and their 95% confidence intervals (CIs) regarding migraine and risk of stroke were computed.
RESULTS: Migraine was associated with increased risks of total stroke, ischemic stroke (IS) and haemorrhagic stroke (HS) (total stroke: OR/RR = 1.62; 95% CI: 1.44-1.83, I2 = 95.8%, p < 0.001; IS: OR/RR = 1.70; 95% CI: 1.47-1.98, I2 = 96.1%, p < 0.001; HS: OR/RR = 1.35; 95% CI: 1.11-1.63, I2 = 85.7%, p < 0.001). Migraine with aura was related to increased risks of total stroke, IS and HS (total stroke: OR/RR = 1.95; 95% CI: 1.62-2.34, I2 = 89.7%, p < 0.001; IS: OR/RR = 2.17; 95% CI: 1.78-2.64, I2 = 89.2%, p < 0.001; HS: OR/RR = 1.30; 95% CI: 1.04-1.62, I2 = 46.3%, p = 0.114). Migraine without aura was related to increased risks of total stroke, IS and HS (total stroke: OR/RR = 1.35; 95% CI: 1.18-1.55, I2 = 85.4%, p < 0.001; IS: OR/RR = 1.34; 95% CI: 1.11-1.62, I2 = 87.8%, p < 0.001; HS: OR/RR = 1.29; 95% CI: 1.04-1.61, I2 = 64.8%, p = 0.023).
CONCLUSIONS: Migraine is associated with a higher risk of total stroke and IS. However, the association between migraine and risk of HS is with more uncertainty.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.